Sponsor Pipeline

Yingbin Liu, MD, PhD, FACS Clinical Trial Pipeline

Data updated daily from ClinicalTrials.gov — last refresh 2026-08-16
2
Active Trials
2
Recruiting
3
Disease Areas
Active Trials by Phase
Not specified
2
Active Trials
NCT IDTitleConditionStatus
Not specified
NCT07045571 MSCAN: ctDNA Methylation as Prognostic and Theranostic Tool for Pancreatic Cancer Pancreatic Neoplasm Recruiting
NCT07176962 A Cell-free DNA Methylation Blood-Based Test for Biliary Tract Cancers Screening Gall Bladder Cancer Recruiting
Disease Areas
Pancreatic Cancer (1) Bladder Cancer (1) Cholangiocarcinoma (1)
Get alerts when Yingbin Liu, MD, PhD, FACS's trials change
Status changes, date slips, and new filings — detected daily, delivered to your inbox.
Start monitoring free